✦ LIBER ✦

Comparison of adriamycin with DNA-adriamycin complex in chemotherapy of experimental tumors and metastases

✍ Scribed by G. Atassi; M. Duarte-Karim; H.J. Tagnon

Book ID: 113145578
Publisher: Elsevier Science
Year: 1975
Weight: 658 KB
Volume: 11
Category: Article
ISSN: 0014-2964
DOI: 10.1016/0014-2964(75)90057-2

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Comparison of adriamycin with the DNA-ad

Comparison of adriamycin with the DNA-adriamycin complex in chemotherapy of L1210 leukemia

✍ Ghanem Atassi; H.J. Tagnon 📂 Article 📅 1974 🏛 Elsevier Science ⚖ 356 KB

Pharmacokinetics of adriamycin and adria

Pharmacokinetics of adriamycin and adriamycin-DNA complex in L1210 mice and men

✍ M. Staquet; M. Rozencweig; M. Duarte-Karim; Y. Kenis 📂 Article 📅 1977 🏛 Elsevier Science ⚖ 252 KB

The comparative toxicity and therapeutic

The comparative toxicity and therapeutic efficacy of adriamycin and the adriamycin-dna complex in the chemotherapy of C3H mice with transplanted mammary adenocarcinoma

✍ Brown, I.; Ward, H.W.C. 📂 Article 📅 1977 🏛 Elsevier Science 🌐 English ⚖ 329 KB

Absorption, fluorescence and resonance R

Absorption, fluorescence and resonance Raman spectra of adriamycin and its complex with DNA

✍ L. Angeloni; G. Smulevich; M.P. Marzocchi 📂 Article 📅 1982 🏛 Elsevier Science 🌐 English ⚖ 432 KB

432 Comparison of Efficiency and Side Ef

432 Comparison of Efficiency and Side Effect of Adriamycin and Doxetaxel and Adriamycin, Cyclophosphamide and Paclitaxel in Patients with Locally Advanced Breast Cancer Receiving Neoadjuvant Chemotherapy

✍ W. Hong; K. Kim; Y. Jung; J. Kim; S. Kang; J. Chun; M. Chun; H. Yim; D. Kang; T. 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 77 KB

Comparison of four-combination chemother

Comparison of four-combination chemotherapy programs in metastatic breast cancer. Comparison of multiple drug therapy with cytoxan, 5-fu and prednisone versus cytoxan and adriamycin, versus cytoxan, 5-Fu and adriamycin, versus cytoxan, 5-Fu and prednisone alternating with cytoxan and adriamycin

✍ Takuma Nemoto; John Horton; Richard Simon; Thomas L. Dao; Dutzu Rosner; Thomas C 📂 Article 📅 1982 🏛 John Wiley and Sons 🌐 English ⚖ 455 KB 👁 2 views

In 126 postmenopausal women with metastatic breast cancer, four chemotherapeutic combination programs were tested. Patients were stratified and randomized to one o f the four programs: (1) fluorouracil, cytoxan and prednisone (CFP): (2) fluorouracil, cytoxan and Adriamycin (CAF); (3) cytoxan and Adr